To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

H3 Biomedicine marks the opening of its Kendall Square office

By Chris Reidy

 |  Globe Staff  

  December 01, 2011

H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, is officially unveiling its new 24,000-square-foot office in Cambridge today, another sign of growth at Kendall Square. H3 Biomedicine currently employs 30 staffers and it looks to add another 40 over the next 12 months. The company’s scientific founders include Stuart L. Schreiber and Todd R. Golub, both of the Broad Institute of Harvard and MIT. H3 Biomedicne has $200 million in research funding from Eisai Inc., a Japanese pharmaceutical company.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help